BOUNDLESS BIO, INC. Basic Shares Outstanding (Weighted Average)
BOUNDLESS BIO, INC. (BOLD) reported Basic Shares Outstanding (Weighted Average) of 22.45 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfSharesOutstandingBasic · last filed 2026-08-07
- BOUNDLESS BIO, INC. weighted average number of shares outstanding, basic for the quarter ending 2026-06-30 was 22.45M shares, a 0.42% increase year-over-year.
- BOUNDLESS BIO, INC. weighted average number of shares outstanding, basic for the quarter ending 2026-03-31 was 22.41M shares, a 0.48% increase year-over-year.
- BOUNDLESS BIO, INC. weighted average number of shares outstanding, basic for the quarter ending 2025-12-31 was 22.40M shares, a 0.34% increase year-over-year.
- BOUNDLESS BIO, INC. weighted average number of shares outstanding, basic for the quarter ending 2025-09-30 was 22.39M shares, a 0.59% increase year-over-year.
- BOUNDLESS BIO, INC. weighted average number of shares outstanding, basic for fiscal 2025 was 22.36M shares, a 31.65% increase from fiscal 2024.
- BOUNDLESS BIO, INC. weighted average number of shares outstanding, basic for fiscal 2024 was 16.98M shares, a 1296.71% increase from fiscal 2023.
- BOUNDLESS BIO, INC. weighted average number of shares outstanding, basic for fiscal 2023 was 1.22M shares.
| Period end | Weighted Average Number of Shares Outstanding, Basic 3 month | Weighted Average Number of Shares Outstanding, Basic 6 month | Weighted Average Number of Shares Outstanding, Basic 9 month | Weighted Average Number of Shares Outstanding, Basic 12 month |
|---|---|---|---|---|
| 2026-06-30 | 22.45M shares 10-Q · filed 2026-08-07 | 22.43M shares 10-Q · filed 2026-08-07 | 22.42M shares derived: average of 3 quarters · filed 2026-08-07 | 22.41M shares derived: average of 4 quarters · filed 2026-08-07 |
| 2026-03-31 | 22.41M shares 10-Q · filed 2026-05-08 | 22.40M shares derived: average of 2 quarters · filed 2026-05-08 | 22.40M shares derived: average of 3 quarters · filed 2026-05-08 | 22.39M shares derived: average of 4 quarters · filed 2026-08-07 |
| 2025-12-31 | 22.40M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-09 | 22.39M shares derived: average of 2 quarters · filed 2026-03-09 | 22.38M shares derived: average of 3 quarters · filed 2026-08-07 | 22.36M shares 10-K · filed 2026-03-09 |
| 2025-09-30 | 22.39M shares 10-Q · filed 2025-11-05 | 22.37M shares derived: average of 2 quarters · filed 2026-08-07 | 22.35M shares 10-Q · filed 2025-11-05 | 22.34M shares derived: average of 4 quarters · filed 2026-08-07 |
| 2025-06-30 | 22.36M shares 10-Q · filed 2026-08-07 | 22.33M shares 10-Q · filed 2026-08-07 | 22.33M shares derived: average of 3 quarters · filed 2026-08-07 | 22.31M shares derived: average of 4 quarters · filed 2026-08-07 |
| 2025-03-31 | 22.30M shares 10-Q · filed 2026-05-08 | 22.31M shares derived: average of 2 quarters · filed 2026-05-08 | 22.29M shares derived: average of 3 quarters · filed 2026-05-08 | 22.23M shares derived: average of 4 quarters · filed 2026-05-08 |
| 2024-12-31 | 22.32M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-09 | 22.29M shares derived: average of 2 quarters · filed 2026-03-09 | 22.20M shares derived: average of 3 quarters · filed 2026-03-09 | 16.98M shares 10-K · filed 2026-03-09 |
| 2024-09-30 | 22.25M shares 10-Q · filed 2025-11-05 | 22.14M shares derived: average of 2 quarters · filed 2025-11-05 | 15.20M shares 10-Q · filed 2025-11-05 | 11.69M shares derived: average of 4 quarters · filed 2025-11-05 |
| 2024-06-30 | 22.02M shares 10-Q · filed 2025-08-05 | 11.64M shares 10-Q · filed 2025-08-05 | 8.17M shares derived: average of 3 quarters · filed 2025-08-05 | 6.44M shares derived: average of 4 quarters · filed 2025-08-05 |
| 2024-03-31 | 1.26M shares 10-Q · filed 2025-05-09 | 1.25M shares derived: average of 2 quarters · filed 2025-05-09 | 1.24M shares derived: average of 3 quarters · filed 2025-05-09 | 1.23M shares derived: average of 4 quarters · filed 2025-05-09 |
| 2023-12-31 | 1.24M shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-27 | 1.24M shares derived: average of 2 quarters · filed 2025-03-27 | 1.23M shares derived: average of 3 quarters · filed 2025-03-27 | 1.22M shares 10-K · filed 2025-03-27 |
| 2023-09-30 | 1.23M shares 10-Q · filed 2024-11-07 | 1.22M shares derived: average of 2 quarters · filed 2024-11-07 | 1.21M shares 10-Q · filed 2024-11-07 | |
| 2023-06-30 | 1.21M shares 10-Q · filed 2024-08-12 | 1.20M shares 10-Q · filed 2024-08-12 | ||
| 2023-03-31 | 1.18M shares 10-Q · filed 2024-05-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| Skye Bioscience, Inc. (SKYE) | United States | $0.061B | -0.48 |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |
| Rein Therapeutics, Inc. (RNTX) | United States | $0.063B | -1.76 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |
| Serina Therapeutics, Inc. (SER) | United States | $0.054B | -2.35 |
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B |